Upload Avatar (500 x 500)
Yang Yongfeng
yangyongfeng@nju.edu.cn
Chinese, English
Jiangsu
Nanjing University
Medical School
  • 1996 - Bachelor's Degree: Henan Xinxiang Medical College
  • 2004 - Doctorate: Xiangya School of Medicine, Central South University
  • Jiangsu Province Outstanding Young and Middle-aged Expert
  • Jiangsu Province Health Leading Talent
  • Jiangsu Province Key Medical Talent
  • Jiangsu Province 333 High-level Talent
  • Jiangsu Province Six Talent Peaks
  • Nanjing City Outstanding Young and Middle-aged Talent
  • 10th China Physician Award
  • 2017 - Jiangsu Province Science and Technology Award, First Prize: Stem cell-related technology for liver failure treatment
  • 2016 - Jiangsu Province Medical New Technology Introduction Award, First Prize: Clinical treatment and infection control of Ebola virus disease
  • 2017 - Jiangsu Province Medical New Technology Introduction Award, First Prize: Rapid dose escalation of amphotericin B in AIDS patients with cryptococcal meningitis
  • 2014 - Jiangsu Province Medical Science and Technology Award, Third Prize: Basic research and clinical exploration of oxymatrine in preventing HBV resistance
  • 2014 - Jiangsu Province Medical New Technology Introduction Award, Second Prize: Application of antiviral methods in the treatment of chronic hepatitis B in children
  • 2013 - Nanjing City Science and Technology Progress Award, First Prize: Optimization of antiviral treatment for chronic hepatitis B
  • 2013 - Jiangsu Province Science and Technology Award, Third Prize: Management and prevention strategies for mother-to-child transmission in pregnant women and infants with chronic HBV infection
  • 2011 - Jiangsu Province Medical New Technology Introduction Award, Second Prize: Long-term efficacy evaluation of interferon treatment for chronic hepatitis B using evidence-based medicine
  • 2009 - Jiangsu Province Medical New Technology Introduction Award, Second Prize: Slow plasma exchange combined with or sequential blood filtration for liver failure treatment
  • 2006 - Nanjing City Science and Technology Progress Award, Third Prize: Individualized combination sequential application of non-biological artificial liver support system for severe hepatitis treatment
Liver Diseases
Infectious Diseases
  • An accurate assay for HCV based on real-time fluorescence detection of isothermal RNA amplification, Yang Yongfeng, 2016
  • MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase, Yang Yongfeng, 2016
  • Label-free electrochemical detection of DNA methyltransferase activity via a DNA tetrahedron-structured probe, Yang Yongfeng, 2016
  • Chiroplasmonic assemblies of gold nanoparticles as a novel method for sensitive detection of alpha-fetoprotein, Yang Yongfeng, 2017
  • Early predictors of acute hepatitis B progression to liver failure, Yang Yongfeng, 2018
  • Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication, Yang Yongfeng, 2019
  • A highly sensitive electrochemical sensor based on DNA Y-Junction for detection of estrogen receptor using target protein protection strategy, Yang Yongfeng, 2019
  • Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis, Yang Yongfeng, 2020
  • Histopathological features and pathological diagnosis of IgG4-related hepatobiliary disease, Yang Yongfeng, 2018
  • Expression of colony-stimulating factor 1 in serum of patients with chronic and acute liver failure and its impact on prognosis, Yang Yongfeng, 2018
  • Clinical observation of changes in condition after discontinuation of nucleos(t)ide analogues in patients with chronic hepatitis B, Yang Yongfeng, 2018
  • Histopathological features and diagnostic approach of genetic metabolic liver disease, Yang Yongfeng, 2018
  • Study on the mutation spectrum of UGT1A1 in hereditary non-hemolytic unconjugated hyperbilirubinemia, Yang Yongfeng, 2018
  • A case of AIDS complicated with hepatitis B virus-related immune reconstitution inflammatory syndrome, Yang Yongfeng, 2019
  • A case of cystic fibrosis mainly manifested by pulmonary infection and liver cirrhosis, Yang Yongfeng, 2019
  • Etiological analysis of 470 cases of unexplained liver disease undergoing liver biopsy, Yang Yongfeng, 2019
  • Construction and reflection on the Fangcang shelter hospital during the COVID-19 epidemic, Yang Yongfeng, 2020
  • Progress in diagnosis and treatment of idiopathic non-cirrhotic portal hypertension, Yang Yongfeng, 2021
  • Study on changes of thyroid hormone and pituitary hormone in patients with liver failure, Yang Yongfeng, 2017
  • Diagnostic approach for unexplained liver disease, Yang Yongfeng, 2018
  • Focus on the study of liver lobule functional zoning, Yang Yongfeng, 2018
  • Imaging and pathological diagnosis of unexplained liver cirrhosis, Yang Yongfeng, 2019
  • Clinical and pathological features of primary biliary cholangitis with negative anti-mitochondrial antibodies, Yang Yongfeng, 2019
  • Improving the pathological literacy of clinical physicians in hepatology, Yang Yongfeng, 2018
  • Comparison of pathological grading and staging scoring systems for chronic hepatitis, Yang Yongfeng, 2018
  • Clinical and pathological aspects of cholestatic liver injury, Yang Yongfeng, 2018
  • Diagnostic approach for unexplained cholestasis, Yang Yongfeng, 2018
  • Clinical features and diagnostic approach of genetic metabolic liver disease, Yang Yongfeng, 2019
  • Value of serum immunoglobulin and autoantibody detection in the diagnosis of autoimmune hepatitis, Yang Yongfeng, 2018
  • Pathological manifestations of idiopathic non-cirrhotic portal hypertension, Yang Yongfeng, 2020
Liver Diseases: Hepatitis Liver Failure Liver Cirrhosis Liver Pathology Liver Imaging Stem Cell Therapy Clinical Diagnosis Pathological Diagnosis Biobank Clinical Cohort Infectious Diseases: Ebola Covid-19 Infectious Disease Control Clinical Treatment Infection Prevention Public Health Epidemic Response Medical Personnel Protection Viral Infections Disease Outbreaks

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.